SMS Lifesciences India (SMS) has agreed to acquire Mahi Drugs Private Limited.

Based in India, the acquirer company is involved in product manufacturing, while the target company, also based in India, is a manufacturer of active pharmaceutical ingredients (APIs).

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Merck & Co has signed an agreement to acquire Viralytics through its subsidiary.

Viralytics will become a subsidiary of Merck, upon completion of the transaction in Q2 2018.

Merck will obtain full rights to Viralytics’s investigational oncolytic immunotherapy CAVATAK (CVA21), as part of the transaction.

Based in the US, Merck is a biopharmaceutical company, while Viralytics is an Australian oncolytic immunotherapies developer.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
“Merck & Co has signed an agreement to acquire Viralytics through its subsidiary.”

Merck has appointed Credit Suisse Securities (USA) as financial advisor, and Baker & McKenzie as legal advisor, while Viralytics selected Lazard as financial advisor and McCullough Robertson as legal advisor for the transaction.

Pharmaceutical company Teijin has agreed to purchase a controlling interest in medical device provider MedTech Heart from venture capital firm Seeds Rocket.

Teijin also will acquire MedTecHeart, a subsidiary of the MedTech Heart, as part of the transaction.

The two companies will be incorporated into a new entity named Teijin MedTecHeart.

Both the acquirer and target companies are based in Japan.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now